Prediction of prematurity

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 6, 1996, Pages 417-427

  Goepfert, Alice R ^a   Goldenberg, Robert L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ALPHA FETOPROTEIN; C REACTIVE PROTEIN; FIBRONECTIN; INTERLEUKIN 6; MATRIX METALLOPROTEINASE;

AMNIONITIS; CLINICAL TRIAL; GENITAL TRACT INFECTION; HOME MONITORING; HUMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; REVIEW; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX DILATATION; UTERINE CERVIX MUCUS; UTERUS CONTRACTION; VAGINITIS;

EID: 0030477702     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199612000-00006     Document Type: Review

References (137)

1. Preterm labor. ACOG Technical Bulletin 206, Washington DC: American College of Obstetrics and Gynecology; 1985.
2. Tucker JM, Goldenberg RL, Davis RO, Copper RL, Winkler CL, Hauth JC: Etiologies of preterm birth in an indigent population: is prevention a logical expectation? Obstet Gynecol 1991, 105:343-347.
3. Anderson BM, Turnbull AC: Relationship between length of gestation and cervical dilation, uterine contractility, and other factors during prenancy. Am J Obstet Gynecol 1969, 105:1207-1214.
4. Blondel B, Le Coutour X, Kaminski M, Chavigny C, Breart G, Sureau C: Prediction of preterm delivery: is it substantially improved by routine vaginal examinations? Am J Obstet Gynecol 1990, 162:1042-1048.
5. Bouyer J, Papiernik E, Dreyfus J, Collin D, Winisdoerffer B, Gueguen S: Maturation signs of the cervix and prediction of preterm birth. Obstet Gynecol 1986, 68:209-214.
6. Leveno KJ, Cox K, Roark ML: Cervical dilation and prematurity revisited. Obstet Gynecol 1986, 68:434-435.
7. Neilson JP, Verkuyl DAA, Crowther CA, Bannerman C: Preterm labor in twin pregnancies: prediction by cervical assessment. Obstet Gynecol 1988, 72:719-723.
8. Papiernik E, Bouyer J, Collin D, Winisdoerffer G, Dreyfus J: Precocious cervical ripening and preterm labor. Obstet Gynecol 1986, 67:238-242.
9. Schaffner F, Schanzer SN: Cervical dilation in the early third trimester. Obstet Gynecol 1966: 27:130-133.
10. Stubbs TM, Van Dorsten P, Miller MC: The preterm cervix and preterm labor: relative risks, predictive values, and change over time. Am J Obstet Gynecol 1986, 155:829-834.
11. Copper RL, Goldenberg RL, Davis RO, Cutter GR, DuBard MB, Corliss DK, Andrew JB: Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm delivery. Am J Obstet Gynecol 1990, 162:748-754.
12. Holcomb WL Jr, Smeltzer JS: Cervical effacement: variation in belief among clinicians. Obstet Gynecol 1991, 78:43-45.
13. Sonek JD, Iams JD, Blumenfeld M, Johnson F, Landon M, Gabbe S: Measurement of cervical length in pregnancy: comparison between vaginal ultrasonography and digital examination. Obstet Gynecol 1990, 76:172-175.
14. Anderson HF: Transvaginal and transabdominal ultrasonography of the uterine cervix during pregnancy. J Clin Ultrasound 1991, 19:77-83.
15. Okitsu O, Mimura T, Nakayama T, Aono T: Early prediction of preterm delivery by transvaginal ultrasonography. Ultrasound Obstet Gynaecol 1992, 2:402-409.
16. Anderson HF, Nugent CE, Wanty SD, Hayaski RH: Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1990, 163:859-867.
17. Iams JD, Paraskos J, Landon MB, Teteris JN, Johnson FF: Cervical sonography in preterm labor. Obstet Gynecol 1994, 84:40-46.
18. Tongsong T, Kamprapauth P, Srisomboon J, Nanapirak C, Piyamongkol N, Sirichotiyakul S: Single transvaginal sonographic measurement of cervical length early in the third trimester as a predictor of preterm delivery. Obstet Gynecol 1995, 86:184-187.
19. Timor-Tritsch IE, Boozarjomehri F, Masakowski Y, Monteagudo A, Chao CR: Can a 'snapshot sagittal view of the cervix by transvaginal ultrasonography predict active preterm labor? Am J Obstet Gynecol 1996, 174:990-995.
20. Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawar A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM: The length of the cervix and the risk of spontaneous preterm delivery. N Engl J Med 1996, 334:567-572. A multicenter prospective observational study of women at low risk for preterm birth, evaluating cervical length by transvaginal ultrasonography and risk of spontaneous preterm birth. A shortened cervix (≤ 25 mm) at 24 and 28 weeks' gestation was associated with spontaneous preterm birth (< 35 weeks).
21. Kushnir O, Izquierdo LA, Smith JF, Blankstein J, Curet LB: Transvaginal sonographic measurement of cervical length: evaluation of twin pregnancies. J Reprod Med 1995, 40:380-382.
22. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, Mercer BM, Meis PJ, Moawad AH, Das A: The preterm prediction study: risk factors in twin gestations. Am J Obstet Gynecol (in press).
23. Herron M, Katz M, Creasy RK: Evaluation of a preterm birth prevention program: preliminary report. Obstet Gynecol 1982, 59:452-456.
24. Beckmann CA, Beckmann CRB, Stanziano GJ, Bergauer NK, Marth CB: Accuracy of maternal perception of preterm uterine activity. Am J Obstet Gynecol 1996, 174:672-675.
25. Iams JD, Johnson FF, O'Shaughnessy RW: A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Am J Obstet Gynecol 1987, 157:638-643.
26. Iams JD, Johnson FF, O'Shaughnessy RW: A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Part II. Am J Obstet Gynecol 1988, 159:595-603.
27. Morrison JC, Martin JN Jr, Martin RW, Gookin KS, Wiser WL: Prevention of preterm birth by ambulatory assessment of uterine activity: a randomized study. Am J Obstet Gynecol 1987, 156:536-543.
28. Hill WC, Fleming AD, Martin RW, Hamer C, Knuppel RA, Lake MF, Watson DL, Welch RA, Bentley DL, Gookin KS et al.: Home uterine activity monitoring is associated with a reduction in preterm birth. Obstet Gynecol 1990, 76(suppl):13-18.
29. Knuppel RA, Lake MF, Watson DL, Welch RA, Hill WC, Fleming AD, Martin RW, Bentley DL, Moenning RK, Morrison JC: Preventing preterm birth in twin gestation: home uterine activity monitoring and perinatal nursing support Obstet Gynecol 1990, 76(suppl):24-27.
30. Dyson DC, Crites YM, Ray DA, Armstrong MA: Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. Am J Obstet Gynecol 1991, 164:756-762.
31. Mou SM, Sunderji SG, Gall S, How H, Patel V, Gray M, Kayne HL, Corwin M: Multicenter randomized clinical trial of home uterine activity monitoring for detection of preterm labor. Am J Obstet Gynecol 1991, 165:858-866.
32. Nagey DA, Bailey-Jones C, Herman AA: Randomized comparison of home uterine activity monitoring and routine care in patients discharged after treatment for preterm labor. Obstet Gynecol 1993, 82:319-323.
33. Watson DL, Welch RA, Mariona FG, Lake MF, Knuppel RA, Martin RW, Johnson C, Bentley DL, Hill WC, Fleming AD et al.: Management of preterm labor patients at home: does daily uterine activity monitoring and nursing support make a difference? Obstet Gynecol 1990, 76(suppl):32-35.
34. Blondel B, Breart G, Berthoux Y, Berland M, Mellier G, Rudingoz RC, Thoulon JM: Home uterine activity monitoring in France, a randomized, controlled trial. Am J Obstet Gynecol 1992, 167:424-429.
35. Grimes DA, Schulz KF: Randomized controlled trials of home uterine activity monitoring: a review and critique. Obstet Gynecol 1992, 79:137-142.
36. Sachs BP, Hellerstein S, Freeman R, Frigoletto F, Hauth JC: Home monitoring of uterine activity. Does it prevent prematurity? N Engl J Med 1991, 325:1374-1377.
37. US Preventive Services Task Force: Home uterine activity monitoring for preterm labor: policy statement JAMA 1993, 270:369-370.
38. Home uterine activity monitoring. ACOG Committee Opinion 172. Washington DC: American College of Obstetrics and Gynecology; 1996.
39. Wapner RJ, Cotton DB, Artal R, Librizzi RJ, Ross MG: A randomized multicenter trial assessing a home uterine activity monitoring device used in the absence of daily nursing contact Am J Obstet Gynecol 1995, 172:1026-1034.
40. The Collaborative Home Uterine Monitoring Study Group: A multicenter randomized controlled trial of home uterine monitoring: active versus sham device. Am J Obstet Gynecol 1995, 173:1120-1127. A multicenter prospective randomized trial of HUAM and rate of spontaneous preterm birth, controlling for daily nursing contact. No significant decrease in the rates of preterm birth (<34 and <37 weeks) were noted with 'active' HUAM.
41. Colton T, Kayne HL, Zhang Y, Heeren T: A meta-analysis of home uterine activity monitoring. Am J Obstet Gynecol 1995, 173:1499-1505.
42. Fiumara MJ: The incidence of prenatal syphilis at the Boston City Hospital. N Engl J Med 1952, 247:48-52.
43. Ricci JM, Fojacco RM, O'Sullivan MJ: Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986-1988. Obstet Gynecol 1989, 74:687-693.
44. Donders GG, Desmyter J, De Wet DH, Van Assche FA: The association of gonorrhea and syphilis with premature birth and low birthweight. Genitourin Med 1993, 69:98-101.
45. Edwards LE, Barrada MI, Hamann AA, Hakanson EY: Gonorrhea in pregnancy. Am J Obstet Gynecol 1978, 132:637-641.
46. Elliott B, Brunham RC, Laga M, Piot P, Ndinya-Achola JO, Maitha G, Cheang M, Plummer FA: Maternal gonococcal infection as a preventable factor for low birth weight. J Infect Dis 1990, 161:531-536.
47. Gibbs RS, Romero MD, Hillier SL, Eschenbach DA, Sweet RL: A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992, 166:1515-1528.
48. Martin DH, Koutsky L, Eschenbach DA, Daling JR, Alexander ER, Benedetti JK, Holmes KK: Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydie trachomatis infections. JAMA 1982, 247:1585-1588.
49. Sweet RL, Landers DJ, Walker C, Schachter J. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol 1987, 156:824-833.
50. Moller M, Thomsen AC, Borch K, Dinesen K, Zdravkovoc M: Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 1984, ii:69-70.
51. White CP, Wilkins EGL, Roberts C, Davidson DC: Premature delivery and group B streptococcal bacteriuria [Letter]. Lancet 1984, ii:586.
52. Hardy PH, Hardy JB, Nell EE, Graham DA, Spence MR, Rosenbaum RC: Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984, ii:333-337.
53. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, Clark L, Pringle G, McCormack WM: Risk factors for prematurity and premature rupture of membranes: a prospective study of vaginal flora in pregnancy. Am J Obstet Gynecol 1984, 150:965-972.
54. Harrison HR, Alexander ER, Weinstein L, Lewis M, Nash M, Sim DA: Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy: epidemiology and outcomes. JAMA 1983, 250:1721-1727.
55. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JB, Rao AV et al.: Association between bacterial vaginosis and preterm delivery of a low-birthweight infant. N Engl J Med 1995, 333:1737-1742. A large multicenter prospective observational study of low-risk women and pregnancy outcome. Women with bacterial vaginosis were at increased risk of delivering preterm (<37 weeks).
56. Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, Johnson F, Iams JD, Thom E, Andres WW: The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol 1995, 173:1231-1235. A multicenter prospective observational study evaluating vaginal infections (bacterial vaginosis, trichomonas vaginitis, monilial vaginitis) and pregnancy outcome. Only bacterial vaginosis was associated with spontaneous preterm birth (<35 weeks).
57. Carey JC, Blackwelder WC, Nugent RP, Matteson MA, Rao AV, Eschenbach DA, Lee ML, Bettig PJ, Regan JA, Geromanos KL et al.: Antepartum cultures for ureaplasma urealyticum are not useful in predicting pregnancy outcome. Am J Obstet Gynecol 1991, 164:728-733.
58. Andrews WW, Goldenberg RL, Hauth JC: Preterm labor: emerging role of genital tract infections. Infect Agents Dis 1995, 4:196-211.
59. Bobitt JR, Hayslip CC, Damato JD: Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor. Am J Obstet Gynecol 1981, 140:947-952.
60. Watts DA, Krohn MA Hillier SL, Eschenbach DA: The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992, 79:351-357.
61. Cassell G, Hauth JC, Andrews W, Cutter G, Goldenberg R: Chorioamnion colonization: correlation with gestational age in women delivered following spontaneous labor versus indicated delivery [Abstract]. Am J Obstet Gynecol 1993, 168:425.
62. Hillier SL, Martins J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA: A case-control study of chorioamnion infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988, 319:972-978.
63. Romero R, Mazor M: Infection and preterm labor. Clin Obstet Gynecol 1988, 31:553-584.
64. Mead PB: Epidemiology of bacterial vaginosis. Am J Obstet Gynecol 1993, 169:446-449.
65. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL: Mid-trimester treatment with metronidazole plus erythromycin reduces preterm birth only in women with bacterial vaginosis. N Engl J Med 1995, 333:1732-1736. A prospective double-blind placebo-controlled trial of women at high risk for preterm birth randomized to antibiotics versus placebo. Antimicrobial treatment was associated with a decreased rate of spontaneous preterm birth (<37 weeks) only in women with bacterial vaginosis.
66. Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW: Bacterial colonization of the vagina during pregnancy in four ethnic groups. Am J Obstet Gynecol 1996, 174:1618-1621.
67. Hill GB: The microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993, 169:450-454.
68. Hillier SL: Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993, 169:455-459.
69. Korn AP, Bolan G, Padian N, Ohm-Smith M, Schachter J, Landers DV: Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gyecol 1995, 85:387-390.
70. Hillier SL, Krohn MA, Cassen E, Easterling TR, Rabe LK, Eschenbach DA: The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Inf Dis 1995, 20(suppl 2):276-278.
71. Morales WJ, Schorr S, Albritton J: Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994, 171:345-349.
72. Joesoef MR, Hillier SL, Wiknjosastro G, Sumampouw H, Linnan M, Norojono W, Idajadi A, Utomo B: Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight Am J Obstet Gynecol 1995, 173:1527-1537.
73. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorsgard K, McFee J: Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995, 173:157-167.
74. Shiono PH, Klebanoff MA, Graubard BI, Berendes HW, Rhoads GG: Birth weight among women of different ethnic groups. JAMA 1986, 255:48-52.
75. Wen SW, Goldenberg RL, Cutter G, Hoffman H, Cliver SP: Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population. Am J Obstet Gynecol 1990, 162:213-218.
76. Kramer MS: Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 1987, 65:663-737.
77. Kleinmann JC, Kessel SS: Racial difference in low birth weight: trends and risk factors. N Engl J Med 1987, 317:749-753.
78. Adams MM, Read JA, Rawlings JS, Harlass FB, Sarno AP, Rhodes PH: Preterm delivery among black and white enlisted women in the United States Army. Obstet Gynecol 1993, 81:65-71.
79. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J: Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994, 308:295-298.
80. Matsurra H, Hakomori S: The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Nat Acad Sci USA 1985, 82:6517-6521.
81. Feinberg RF, Kliman HJ, Lockwood CJ: Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol 1991, 138:537-543.
82. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L, Garite TJ: Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991, 325:669-674.
83. Lockwood CJ, Feinberg RF, Kliman H, Garite TJ, Senyei AE: Cervicovaginal oncofetal fibronectin in preterm labor patients: a result of chorion extracellular matrix degradation [Abstract]. Am J Obstet Gynecol 1991, 164:374.
84. Morrison JC, Albert JR, McLaughlin BN, Whitworth NS, Roberts WE, Martin RW: Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993, 168:538-542.
85. Irion O, Matute J, Bischof P, Beguin F: Cervical oncofetal fibronectin as a predictor of preterm delivery [Abstract]. Am J Obstet Gynecol 1994, 170:384.
86. Nageotte MP, Casal D, Senyei AE: Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994, 170:20-25.
87. Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, Lockitch G: Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995, 173:141-145.
88. Bartnicki J, Casal D, Kreaden US, Saling E, Netter K: Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birthweight infants. Am J Obstet Gynecol 1996, 174:971-974.
89. Parker J, Bell R, Brennecke S: Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labor as a predictor of delivery before 34 weeks' gestation. Aust NZ Obstet Gynaecol 1995, 35:257-261.
90. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A: Fetal fibronectin as a predictor of preterm birth in symptomatic patients - a multicenter trial [Abstract]. Am J Obstet Gynecol 1996, 174:303.
91. Hellemans P, Gerris J, Verdonk P: Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol 1995, 102:207-212.
92. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D: The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996, 87:643-648. A multicenter prospective observational study of low-risk women evaluating cervicovaginal fetal fibronectin and risk of preterm birth. A positive fetal fibronectin test was associated with spontaneous preterm birth at less than 34 weeks' gestation and a positive test at 24-26 weeks' gestation was most sensitive in predicting spontaneous preterm birth (<34 weeks), with a sensitivity at 24 weeks of 63%.
93. Morrison JC, Naef RW, Botti JJ, Katz M, Belluomini JM, McLaughlin BN: Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol 1996, 87:649-655.
94. Goldenberg RL, Thom E, Moawad AH, Johnson F, Roberts J, Caritis SN: The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. Obstet Gynecol 1996, 87:656-660.
95. Hillier SL, Krohn MA, Kiviat NB, Watts DH, Eschenbach DA: Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 1991, 165:955-961.
96. Romero R, Munoz H, Gomez R, Sherer DM, Ghezzi F, Ghidini A, Alfi O, DeVore G, Randolph L: Two thirds of spontaneous abortions/fetal deaths after midtrimester genetic amniocentesis are the result of a pre-existing subclinical inflammatory process of the amniotic cavity [Abstract]. Am J Obstet Gynecol 1995, 172:261.
97. Harger JH, Meyer MP, Amortegui A, MacPherson TA, Kaplan L, Mueller-Heubach E: Low incidence of positive amniotic fluid cultures in preterm labor at 27-32 weeks in the absence of clinical evidence of chorioamnionitis. Obstet Gynecol 1991, 77:228-234.
98. Gravett MG, Hummel D, Eschenbach DE, Holmes KK: Preterm labor associated with subclinical amniotic fluid infection and with subclinical bacterial vaginosis. Obstet Gynecol 1986, 67:229-237.
99. Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH: Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered following spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995, 173:606-612.
100. Cassell G, Andrews W, Hauth J, Cutter G, Hamrick W, Baldus K, Waites K: Isolation of microorganisms from the chorioamnion is twice that from amniotic fluid at cesarean delivery in women with intact membranes [Abstract]. Am J Obstet Gynecol 1993, 168:424.
101. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA: The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histological chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993, 81:941-948.
102. Cammu H, Goosens A, Devde M, Temmerman M, Foulon W, Amy J: C-reactive protein in preterm labour: association with outcome of tocolysis and placental histology. Br J Obstet Gynaecol 1989, 96:314-319.
103. Romero R, Brody DT, Oyarzun E, Mazor M, Wu YK, Hobbing JC, Durum SK: Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989, 160:1117-1123.
104. Romero R, Manogue JR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, Cerami A: Infection and labor. IV. Cachetin-tumor necrosis factor in the amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1989, 161:336-341.
105. Gravett MG, Haluska GJ, Edwards JL, Cook MJ, Baggia S, Witkin SS, Novy MJ: Amniotic fluid infection (AFI) and preterm labor in rhesus macaques [Abstract]. Am J Obstet Gynecol 1992, 166:290.
106. Romero R, Avila C, Santhanam U, Sehgal PB: Amniotic fluid interleukin-6 in preterm labor: association with infection. J Clin Invest 1990, 85:1392-1400.
107. Burrus DR, Ernest JM, Veille JC: Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idiopathic preterm labor. Am J Obstet Gynecol 1995, 173:1258-1262.
108. Foulon W, Van Kiedererke D, Demanet C, Decatte L, Dewaele M, Naessens A: Markers of infection and their relationship to preterm delivery. Am J Perinatol 1995, 12:208-211.
109. Yoon BH, Yang SH, Jun JK, Park KH, Kim CJ, Romero R: Maternal blood C-reactive protein, white blood cell count, and temperature in preterm labor: a comparison with amniotic fluid white blood cell count Obstet Gynecol 1996, 87:231-237.
110. Wenstrom DK, Andrews WW, Tamura T, DuBard M, Johnston KE, Hemstreet GP: Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss [Abstract]. Am J Obstet Gynecol 1996, 175:830-833.
111. Rizzo G, Capponi A, Rinaldo D, Arduini D, Tedeschi D, Romanini C: Interleukin-6 (IL-6) concentrations in cervical secretions identify intra-amniotic infection in patients with preterm labor (PTL) [Abstract], Am J Obstet Gynecol 1996, 175:812-817.
112. Brock DJH, Barron L: Measurement of placental alkaline phosphatase in maternal plasma as an indicator of subsequent low birth weight outcome. Br J Obstet Gynaecol 1988, 95:79-83.
113. Best RG, Meyer RE, Shiley CF: Maternal serum placental alkaline phosphatase as a marker for low birth weight: results of a pilot study. South Med J 1991, 84:740-742.
114. Meyer RE, Thompson SJ, Addy CL, Garrison CZ, Best RG: Maternal serum placental alkaline phosphatase level and risk for preterm delivery. Am J Obstet Gynecol 1995, 173:181-186.
115. Burton BK, Sowers SG, Nelson LH: Maternal serum α-fetoprotein screening in North Carolina: experience with more than twelve thousand pregnancies. Am J Obstet Gynecol 1983, 146:439-444.
116. Burton BK: Elevated maternal serum alpha-fetoprotein (MSAFP): interpretation and follow-up. Clin Obstet Gynecol 1988, 31:293-305.
117. Waller DK, Lustig LS, Cunningham GC, Golbus MS, Hook EB: Second trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991, 325:6-10.
118. Williams MA, Hickok DE, Zingheim RW, Luthy DA, Kimelnan J, Nyberg DA, Mahony BS: Elevated maternal serum α-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 1992, 167:1032-1067.
119. Wenstrom KD, Sipes SL, Williamson RA, Grant SS, Trawick DC, Estle LC: Prediction of pregnancy outcome with single versus serial maternal serum α-fetoprotein tests. Am J Obstet Gynecol 167:1529-1533.
120. Wenstrom KD, Owen J, Davis RO, Brumfield CG: Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol 1986, 87:213-216.
121. Kushner I: The acute phase response: an overview. Methods Enzymol 1988, 163:373-383.
122. Maymon R, Bahari C, Moroz C: Placental isoferritin: a new serum marker in toxemia of pregnancy. Am J Obstet Gynecol 1989, 160:681-684.
123. Raman L, Pawashe AB, Yasodhara P: Hyperferritinemia in pregnancy induced hypertension and eclampsia. J Postgrad Med 1992, 37:65-67.
124. Entman SS, Richardson LD, Killam AP: Elevated serum ferritin in the altered ferrokinetics of toxemia of pregnancy. Am J Obstet Gynecol 1982, 144:418-422.
125. Tamura T, Goldenberg RL, Johnston KE, Cliver SP, Hickey CA: Serum ferritin: a predictor of early spontaneous preterm delivery. Obstet Gynecol 1996, 87:360-365.
126. Goldenberg RL, Tamura T, DuBard M, Johnston KE, Copper RL, Neggers Y: Plasma ferritin and pregnancy outcome. Am J Obstet Gynecol 1996 (in press).
127. McGregor JA, Jackson GM, Lachelin GCL, Goodwin TM, Artal R, Hastings C, Dullien V: Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol 1995, 173:1337-1342.
128. Wolfe DCA, Patel SP, Linton EA, Campbell EA, Anderson J, Dornhorst A, Loury PJ, Jones MT: Plasma corticotropin-releasing factor (CRF) in abnormal pregnancy. Br J Obstet Gynaecol 1988, 95:1003-1006.
129. Warren WB, Patrick SL, Goland RS: Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labour. Am J Obstet Gynecol 1992, 166:1198-1207.
130. Jones SA, Lao T, Hannah ME, Weston I, Myhr T: Corticotropin-releasing hormone and preterm labor [Abstract]. J Soc Gynecol Invest 1995, 2:286.
131. Berkowitz GS, Lapinski RH, Lockwood CH, Florio P, Blackmore-Prince C, Petraglia F: Corticotropin-releasing factor and its binding protein: maternal serum levels in term deliveries. Am J Obstet Gynecol 1996, 174:1477-1483.
132. Matrisian L: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990, 6:131-135.
133. Woessner F: Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991, 5:2145-2154.
134. Vadillo-Ortega F, Gonzalez-Avila F, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss JF: 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995, 146:148-156.
135. Draper D, McGregor J, Hall J, Jones W, Beutz M, Heine RP, Porreco R: Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol 1995, 173:1506-1512.
136. Vadillo-Ortega F, Hernandez A, Gonzales-Avila G, Bermejo L, Iwata K, Strauss JF: Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996, 174:1371-1376.
137. Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad AH, Copper RL, Das A, Thom E, Johnson F, McNellis D, Roberts J: Pathways to prematurity [Abstract]. Am J Obstet Gynecol 1996, 174:308.